Literature DB >> 20169669

Intraperitoneal dissemination of endometrial cancer cells after hysteroscopy: a systematic review and meta-analysis.

Nikolaos P Polyzos1, Davide Mauri, Spyridon Tsioras, Christina I Messini, Antonis Valachis, Ioannis E Messinis.   

Abstract

INTRODUCTION: Hysteroscopy is a diagnostic procedure with a high accuracy in diagnosing endometrial cancer. Because of the increase of intrauterine pressure during distention media inflation, several retrospective studies postulated that it may result in cancer cell dissemination within the peritoneal cavity through the fallopian tubes. We therefore set to estimate whether hysteroscopy increases the risk for intraperitoneal cancer cell dissemination in patients with endometrial cancer and the risk of disease upstaging in patients with clinically early-stage disease.
METHODS: We searched the PubMed, the ISI Web of Science, and the Cochrane Library through July 2009. Eligible trials were all controlled clinical trials in which patients were allocated to hysteroscopy (alone or after other diagnostic procedure, eg, dilation and curettage and biopsy) versus any other diagnostic procedure except hysteroscopy or no procedure before surgery for endometrial carcinoma.
RESULTS: Nine trials were included in our analysis. One thousand fifteen patients with histologically proven endometrial carcinoma were allocated to hysteroscopy or no hysteroscopy before surgery. Hysteroscopy resulted in a significantly higher rate of malignant peritoneal cytology (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.13-2.79; P = 0.013) and significantly higher disease upstaging owing solely to the presence of malignant cells in the peritoneal cavity (OR, 2.61; 95% CI, 1.47-4.63; P = 0.001) compared with no hysteroscopy. When isotonic sodium chloride was used as distention medium, hysteroscopy resulted in a statistically significant higher rate of malignant peritoneal cytology (OR, 2.89; 95% CI, 1.48-5.64; P = 0.002), whereas a nonsignificant trend for higher malignant cells was observed in patients allocated to the hysteroscopy group (OR, 3.23; 95% CI, 0.94-11.09; P = 0.062) when inflated media pressure reached or exceeded 100 mm Hg.
CONCLUSIONS: Hysteroscopy in patients with endometrial cancer hints a risk for cancer cell dissemination within the peritoneal cavity. Prospective and sufficiently powered trials are needed to clarify whether the risk of cancer cell spreading is correlated with worse prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20169669     DOI: 10.1111/igc.0b013e3181ca2290

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  19 in total

1.  Does duration of hysteroscopy increase the risk of disease recurrence in patients with endometrial cancer? A multi-centre trial.

Authors:  Clemens Tempfer; Georg Froese; Bernd Buerkle; Stephan Polterauer; Christoph Grimm; Nicole Concin; Gerda Hofstetter; Monika Weigert; Martin K Oehler
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

2.  Can magnetic resonance spectroscopy differentiate endometrial cancer?

Authors:  Jie Zhang; Shifeng Cai; Changzhong Li; Xichao Sun; Xue Han; Chunrun Yang; Caixia Fu; Qingwei Liu; Yinghui Xin; Yuanyuan Zong
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

3.  Two cases of successful pregnancies after hysteroscopic removal of endometrioid adenocarcinoma grade I, stage IA, in young women with Lynch syndrome.

Authors:  Ingrid Marton; Hrvojka Soljacic Vranes; Vladimir Sparac; Igor Maricic; Krunoslav Kuna; Miroslav Kopjar
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-01-06

4.  Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.

Authors:  Koji Matsuo; Shinya Matsuzaki; David J Nusbaum; Hiroko Machida; Yoshikazu Nagase; Brendan H Grubbs; Lynda D Roman; Jason D Wright; Philipp Harter; Maximilian Klar
Journal:  Eur J Cancer       Date:  2020-05-17       Impact factor: 9.162

5.  Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator : Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer.

Authors:  Franziska Siegenthaler; Silke Johann; Sara Imboden; Nicolas Samartzis; Haiyan Ledermann-Liu; Dimitri Sarlos; Markus Eberhard; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2022-09-04       Impact factor: 4.339

6.  Technical modifications in the robotic-assisted surgical approach for gynaecologic operations.

Authors:  Frederik Peeters; Zvi Vaknin; Susie Lau; Claire Deland; Sonya Brin; Walter H Gotlieb
Journal:  J Robot Surg       Date:  2010-11-10

7.  Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.

Authors:  Koji Matsuo; David J Nusbaum; Shinya Matsuzaki; Erica J Chang; Lynda D Roman; Jason D Wright; Philipp Harter; Maximilian Klar
Journal:  Gynecol Oncol       Date:  2020-07-18       Impact factor: 5.482

8.  Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013-12-30

Review 9.  Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis.

Authors:  Katharine L Sodek; K Joan Murphy; Theodore J Brown; Maurice J Ringuette
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

10.  Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage.

Authors:  Andraz Dovnik; Bojana Crnobrnja; Branka Zegura; Iztok Takac; Maja Pakiz
Journal:  Radiol Oncol       Date:  2016-05-30       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.